Ferritin Target for Neuropathic Symptoms
For neuropathic symptoms specifically, target a serum ferritin level ≥50 ng/mL, with optimal treatment occurring when ferritin is ≤75 ng/mL, based on restless legs syndrome guidelines which represent the strongest evidence linking ferritin levels to neurological symptoms.
Evidence-Based Thresholds
The most recent and highest-quality guideline addressing ferritin levels and neuropathic symptoms comes from the 2025 American Academy of Sleep Medicine guidelines for restless legs syndrome (RLS) 1. RLS represents the best-studied model of ferritin-responsive neuropathic symptoms, and these guidelines recommend:
- Iron supplementation (oral or IV) when serum ferritin ≤75 ng/mL or transferrin saturation <20%
- IV iron specifically when ferritin is between 75-100 ng/mL
- Blood draw timing: morning collection, avoiding iron-containing supplements/foods for 24 hours prior
This threshold is substantially higher than general population iron deficiency criteria, reflecting the specific neurological requirements for adequate iron stores.
Supporting Evidence from Other Neuropathic Conditions
While the RLS guidelines provide the strongest direct evidence, emerging research supports the ferritin-neuropathy connection:
- A 2026 study found that lower ferritin levels were significantly associated with neuropathic pain in fibromyalgia patients (p=0.005), though disease severity remained the strongest predictor 2
- Studies in beta-thalassemia demonstrate that elevated serum ferritin correlates with worsening neuropathy, suggesting a U-shaped relationship where both deficiency and overload cause neurological damage 3, 4
Clinical Algorithm
Step 1: Measure iron parameters
- Serum ferritin (morning, fasting from iron supplements ≥24 hours)
- Transferrin saturation (calculated from serum iron/TIBC)
Step 2: Interpret results for neuropathic symptoms
- Ferritin ≤75 ng/mL OR TSAT <20% → Initiate iron supplementation
- Ferritin 75-100 ng/mL → Consider IV iron (more effective than oral)
- Ferritin >100 ng/mL → Iron unlikely to be causative; investigate other etiologies
Step 3: Route selection
- Oral iron: Ferritin ≤75 ng/mL with good GI tolerance (200 mg elemental iron daily in divided doses) 5
- IV iron: Ferritin 75-100 ng/mL, or failed oral therapy, or need for rapid repletion 1
Step 4: Monitoring
- Recheck ferritin and TSAT 4-8 weeks after initiating therapy 6
- Target ferritin ≥50 ng/mL for symptom resolution
- Avoid ferritin >500 ng/mL (risk of iron overload complications) 7
Critical Caveats
Inflammation confounds ferritin interpretation: Ferritin is an acute-phase reactant. In inflammatory conditions, a ferritin <100 ng/mL may still indicate iron deficiency despite appearing "normal" 8, 9. Consider:
- Transferrin saturation <20% as more reliable in inflammation
- Soluble transferrin receptor (sTfR) if available
- Reticulocyte hemoglobin content (CHr <28 pg) 6
The ferritin threshold for neurological symptoms differs from anemia thresholds: General iron deficiency is diagnosed at ferritin <30 ng/mL 8, but neurological manifestations may occur at higher levels (≤75 ng/mL) because the brain has distinct iron requirements 1.
Iron overload also causes neuropathy: In conditions like beta-thalassemia, ferritin >1000 ng/mL correlates with peripheral neuropathy 4. This creates a therapeutic window where both deficiency and excess are harmful.
Practical Implementation
For a patient presenting with neuropathic symptoms and ferritin of 60 ng/mL:
- Initiate oral iron 200 mg elemental daily (e.g., ferrous sulfate 325 mg TID = 195 mg elemental iron) 5
- Take on empty stomach, separated from other medications
- Recheck ferritin at 8 weeks
- If ferritin remains <75 ng/mL despite oral therapy, switch to IV iron (ferric carboxymaltose 1000 mg or iron isomaltoside up to 20 mg/kg) 1
- Reassess neuropathic symptoms 4-8 weeks post-repletion
The evidence strongly supports treating iron deficiency when ferritin ≤75 ng/mL in patients with neuropathic symptoms, with IV iron preferred for ferritin 75-100 ng/mL range 1.